Gaithersburg-Based Novavax Raising $200M To Fund COVID-19, Flu Vaccine Efforts
The Gaithersburg-based company Novavax announced this week it plans to raise around $200 million to not only fund its coronavirus vaccine work, but also its flu vaccine, NanoFlu.